ME

23andMe (ME)

23andMe Holding Company

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ME

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/05	20 : 00	GlobeNewswire Inc.	23andMe Launches New Genetic Report on Bipolar Disorder	NASDAQ:ME	23andMe Holding Company
2024/06/04	20 : 00	GlobeNewswire Inc.	23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community	NASDAQ:ME	23andMe Holding Company
2024/06/03	21 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/06/03	21 : 00	GlobeNewswire Inc.	23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting	NASDAQ:ME	23andMe Holding Company
2024/05/29	21 : 00	GlobeNewswire Inc.	Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history	NASDAQ:ME	23andMe Holding Company
2024/05/25	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/05/24	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/24	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/05/24	05 : 05	GlobeNewswire Inc.	23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/05/22	05 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/22	05 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/14	20 : 00	GlobeNewswire Inc.	Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals	NASDAQ:ME	23andMe Holding Company
2024/05/11	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/05/10	05 : 50	GlobeNewswire Inc.	23andMe to Report Q4 and Full Year FY2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/05/01	00 : 00	Business Wire	Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case	NASDAQ:ME	23andMe Holding Company
2024/04/25	05 : 05	GlobeNewswire Inc.	23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:ME	23andMe Holding Company
2024/04/18	21 : 00	GlobeNewswire Inc.	23andMe announces CEO’s intention to pursue a potential take-private	NASDAQ:ME	23andMe Holding Company
2024/04/06	05 : 05	GlobeNewswire Inc.	23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ME	23andMe Holding Company
2024/03/20	20 : 30	GlobeNewswire Inc.	23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6	NASDAQ:ME	23andMe Holding Company
2024/03/19	21 : 00	GlobeNewswire Inc.	23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago	NASDAQ:ME	23andMe Holding Company
2024/03/06	21 : 30	GlobeNewswire Inc.	23andMe Launches New Genetic Reports on Common Forms of Cancer	NASDAQ:ME	23andMe Holding Company
2024/03/06	06 : 30	GlobeNewswire Inc.	23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ME	23andMe Holding Company
2024/02/22	06 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/02/08	06 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ME	23andMe Holding Company
2024/02/08	06 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/02/08	06 : 01	GlobeNewswire Inc.	23andMe Reports Third Quarter Fiscal 2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/02/06	21 : 00	Business Wire	Moneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc.	NASDAQ:ME	23andMe Holding Company
2024/01/31	21 : 50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/01/31	12 : 12	GlobeNewswire Inc.	23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay	NASDAQ:ME	23andMe Holding Company
2024/01/31	07 : 00	Business Wire	Nighthawk Gold Obtains Final Court Order for the Proposed Arrangement	NASDAQ:ME	23andMe Holding Company